Michel Joannic

Title: Michel Joannic: Innovator in Pharmaceutical Compounds

Introduction

Michel Joannic is a notable inventor based in Neuilly-sur-Marne, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit .beta.-adrenergic properties. His work is particularly relevant for medical applications, including the treatment of asthma and premature labor.

Latest Patents

Michel Joannic holds a patent for novel compounds with .beta.-adrenergic properties. The patent details a compound known as 1-[1-benzimidazolyl] N-[2-(4-hydroxy 3-methoxy phenyl) 2-hydroxy ethyl]3-amino butane, along with its addition salts with pharmaceutically acceptable non-toxic inorganic or organic acids, and the hydrates of said salts. This innovation is crucial for advancing therapeutic options in respiratory and obstetric care. He has 1 patent to his name.

Career Highlights

Throughout his career, Michel Joannic has been associated with Laboratoire Roger Bellon, where he has focused on research and development in pharmaceutical sciences. His expertise in .beta.-adrenergic compounds has positioned him as a key figure in the industry.

Collaborations

Michel has collaborated with notable colleagues, including Francoise Roquet and Marcel E Pesson. These partnerships have contributed to the advancement of his research and the successful development of innovative pharmaceutical solutions.

Conclusion

Michel Joannic's contributions to the field of pharmaceuticals through his innovative compounds demonstrate his commitment to improving medical treatments. His work continues to have a lasting impact on the healthcare industry.